Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  diaziquone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 100 for your search:
Start Over
Phase III Chemotherapy with AZQ vs BCNU for Grade III/IV Astrocytoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAOP-8182
Phase III Comparison of AZQ vs BCNU Following Full-Course Postoperative Radiotherapy in Patients with Primary Anaplastic Brain Tumors (Summary Last Modified 04/88)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-140882R5, NCI-T83-1073D, T83-1073
Phase III Chemotherapy with AZQ/CCNU/CACP Administered in a Standard Sequence vs a Sequence Determined by In-Vitro Assay Results for Malignant Brain Tumors
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, NINDS
Protocol IDs: NINDS-83-N-63, NCI-T84-0415N, T84-0415
Phase III Chemotherapy with AZQ vs BCNU in Adult Patients with Malignant Primary Tumors of the CNS
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: OSP-84234, NCI-V85-0081
Phase III Chemotherapy with AZQ vs BCNU in Adult Patients with Malignant Tumors of the Central Nervous System (Summary Last Modified 06/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: OSU-8503, NCI-T85-0058D, T85-0058
Phase III Comparison of 24-Hour AZQ Infusion vs BCNU in Adults with High-Grade Supratentorial Glioma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8737, INT-0093
Phase III Randomized Trial of Intensification with ARA-C vs Sequential ARA-C, CTX/VP-16, and DHAD/AZQ in Patients Under 60 Years Old with AML in First Remission
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI
Protocol IDs: CLB-9222, CALGB-9222
Phase I-II Chemotherapy with Aziridinylbenzoquinone for Previously Treated Acute Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8018
Phase I/II Chemotherapy with Intrathecal AZQ in Patients with Malignant Meningeal Spread of Refractory Leukemia, Lymphoma, or Solid Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 3
Sponsor: NCI
Protocol IDs: NCI-83-C-0039D, NCI-W83-0836, W83-0836
Phase I/II Chemotherapy with AZQ for Refractory Acute Leukemia and CML in Blast Crisis
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DT-8128, NCI-T83-0942C, T83-0942
Phase I/II Chemotherapy with AZQ for Recurrent Primary Brain Tumors or Brain Metastasis
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under 70
Sponsor: NCI
Protocol IDs: UMCC-8029, NCI-T83-0872W
Phase I/II Chemotherapy with AZQ in Children and Adolescents with Advanced Malignant Disease in Relapse and Resistant to Standard Therapy (Summary Last Modified 06/97)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8136/8138, POG-8138
Phase I/II Chemotherapy with AZQ for Refractory Adult Acute Leukemia and Blastic Phase Chronic Myelocytic Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: UMCC-8224, NCI-W82-1275, W82-1275
Phase I/II Study of Radiotherapy plus Chemotherapy with AZQ in Patients with Malignant Astrocytoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-8409, RTOG-84-09
Phase II Master Protocol Evaluation of Single-agent or Combination Chemotherapy for Relapsed or Refractory Adult ANLL --- AZQ/AMSA (Phase I/II (Summary Last Modified 06/97)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8521, CALGB-8521
Phase I/II Chemotherapy with AZQ in Children and Adults with Recurrent Malignant Brain Tumors Refractory to Nitrosourea Therapy (Summary Last Modified 06/97
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: BTRC-8521, NCI-T85-0199H, T85-0199
Phase II Chemotherapy with AZQ for Stage IV Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DT-8024
Phase II Chemotherapy with AZQ for Metastatic Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DT-8023
Phase II Chemotherapy with AZQ for Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8020
Phase II Chemotherapy with Aziridinylbenzoquinone for Malignant Primary Brain Tumor
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-8048
Phase II Chemotherapy with Aziridinylbenzoquinone for Metastatic Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DT-8074
Phase II Chemotherapy with AZQ for Hodgkin's Disease and non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8070
Phase II Radiotherapy plus Chemotherapy with AZQ vs PCNU for New or Recurrent Primary Brain Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: BTSG-8120
Phase II Chemotherapy with AZQ for Lung Carcinoma of All Cell Types
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-LUN-81214
Phase II Chemotherapy with AZQ for Advanced Adenocarcinoma of the Colon and Rectum
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7940/45
Start Over